Xilinx (XLNX), Philip Morris (PM), Altria Group (MO), Health Management (HMA), ASML (ASML) and Human Genome (HGSI) were upgraded or downgraded by analysts.
Xilinx (XLNX) downgraded to Hold from Buy at Deutsche Bank.Deutsche Bank downgraded Xilinx citing valuation following the company's Q3 results. The firm raised its price target for shares to $38 from $34.
Philip Morris (PM) initiated with an Outperform at CLSA Target $86.
Altria Group (MO) initiated with an Outperform at CLSA Target $32.
Health Management (HMA) upgraded to Buy from Hold at Deutsche Bank.Deutsche Bank upgraded Health Management citing the recent pullback shares and the company's attainable 2012 guidance. The firm lowered its price target for shares to $8.50 from $9.50.
ASML (ASML) downgraded to Hold from Buy at Banco Santander.
Human Genome (HGSI) initiated with a Buy at Maxim Target $14.
For the latest updates on the stock market, visit,
http://daytradingstock-blog.blogspot.com/